| BTG Share Price | |||
|---|---|---|---|
| Price | 125.00 | Open | 126.00 |
| Bid | 125.00 | High | 126.50 |
| Ask | 125.50 | Low | 125.00 |
| Change | -2.50 (-1.96%) | Close | 127.50 |
| Volume | 174,472 | ||
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 161.11m |
| Market Cap | £201.38m |
| PE Ratio | 31.25 |
| EPS | 4.00 |
| Year High | 129.00 |
|---|---|
| Year High Date | 09-Jun-2026 |
| Year Low | 106.00 |
| Year Low Date | 23-Oct-2025 |
| Dividend | 4.00 |
| Yield | 3.20% |
| # Trades | 40 |
|---|---|
| Vol. Sold | 35,952 |
| Sold Value | £45.42k |
| Vol. Bought | 73,561 |
| Bought Value | £92.76k |
| Market Size | 3,000 |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 12-Jun-26 | 14:37:27 | 125.2593 | 430 | Buy* | 125.00 | 125.50 | 538.61 | O Ordinary |
| 12-Jun-26 | 14:34:10 | 125.49 | 10,000 | Buy* | 125.00 | 125.50 | 12.55k | O Ordinary |
| 12-Jun-26 | 14:34:01 | 125.455 | 10,000 | Buy* | 125.00 | 125.50 | 12.55k | O Ordinary |
| 12-Jun-26 | 14:14:32 | 125.25 | 5,585 | Buy* | 124.50 | 125.50 | 6,995 | O Ordinary |
| 12-Jun-26 | 14:04:52 | 125.125 | 3,086 | Sell* | 124.50 | 126.00 | 3,861 | O Ordinary |
| 12-Jun-26 | 13:19:08 | 125.2603 | 5,000 | Buy* | 124.50 | 126.00 | 6,263 | O Ordinary |
| 12-Jun-26 | 12:15:22 | 125.5073 | 21,414 | Unknown* | 124.50 | 126.00 | 26.88k | O Ordinary Delayed publication |
| 12-Jun-26 | 13:14:37 | 126.00 | 64 | Buy* | 124.50 | 126.00 | 80.64 | O Ordinary Trade was executed as an SI |
| 12-Jun-26 | 13:12:27 | 126.00 | 384 | Buy* | 124.50 | 126.00 | 483.84 | O Ordinary Trade was executed as an SI |
| 12-Jun-26 | 13:08:30 | 126.00 | 385 | Buy* | 124.50 | 126.00 | 485.10 | O Ordinary Trade was executed as an SI |
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 01-Apr-26 | 31-Mar-26 | Transfer To | Richard W Traynor held the position of Executive Chairman at the time of this trade.Richard W Traynor | 0.00 | 3 | 27,178,977 | |
| 16-Aug-19 | 16-Aug-19 | Buy | Duncan Kennedy held the position of CFO at the time of this trade.Duncan Kennedy | 565.07 | GBX | 1,061 | 298,135 |
| 16-Aug-19 | 16-Aug-19 | Exercise of Option | Duncan Kennedy held the position of CFO at the time of this trade.Duncan Kennedy | 520.53 | GBX | 1,729 | 298,135 |
| 16-Aug-19 | 16-Aug-19 | Buy | Dame Pamela Louise Makin held the position of CEO at the time of this trade.Dame Pamela Louise Makin | 840.00 | GBX | 2,251,925 | 4,503,842 |
| 16-Aug-19 | 16-Aug-19 | Exercise of Option | Dame Pamela Louise Makin held the position of CEO at the time of this trade.Dame Pamela Louise Makin | 0.00 | 474,861 | 2,251,917 |
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.